title: [NURSING CARE TO A PATIENT WITH INTRAVESICAL TREATMENT].
abstract: BACKGROUND
  Bladder cancer is one of the most frequent in developed countries. It is the 4th most frequent cancer in men and the 9th in women. The main risk factor is the smoking habit and its main symptom is hematuria. One of the therapies used in its treatment is the Bacillus Calmette-Guerin intravesical (BCG).
  
  
  OBJECTIVE
  TO carry out a specific care plan to a patient treated with BCG and improve the information delivered to the patient and family.
  
  
  METHODS
  An observational study of a nursing plan of care through a clinical case. A bibliographical research was carried out in the main Spanish and English databases to collect articles published in the last 5 years. Subsequently, the studies of the Spanish M.a T Luis, C. Ferndndez and M.a V. Navarro were adopted in the model suggested by V. Henderson and NANDA, NIC and NOC taxonomy.
  
  
  RESULTS
  The nursing assessment is performed through V. Henderson's 14 needs and the Collaboration Problem was detected: Hematuria, secondary to bladder cancer and the nursing diagnosis: <<Disposition to improve the management of the own health expressed by the wish of managing the disease>>. For the planning and execution the following NOC were selected: Knowledge: management of the cancer and Knowledge: therapeutic procedure, and the NIC and its corresponding activities and their evaluation.
  
  
  CONCLUSIONS
  The Nursing Care Process application with a personalised and standardised language, guarantees a quality healthcare and continuity. Moreover, it sets common targets for the nursing team. It tries to show how an appropriate control of the symptoms can be carried out at home, when the cares are taught and organised by adapting the oral or written information to each patient.
authors.forename: Míriam Paula
authors.initials: MP
authors.lastname: Marcos Espino
authors.forename: Eva
authors.initials: E
authors.lastname: Tizón Bouza
mesh_terms: D000276:Adjuvants, Immunologic / Q000008:administration & dosage*; D000283:Administration, Intravesical; D000368:Aged; D001500:BCG Vaccine / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D010347:Patient Care Planning; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000451:nursing*
chemical_list: D000276:Adjuvants, Immunologic; D001500:BCG Vaccine